Share-based Payment Arrangement, Expense of Corbus Pharmaceuticals Holdings, Inc. from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Corbus Pharmaceuticals Holdings, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • Corbus Pharmaceuticals Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $1,429,000, a 71% decline year-over-year.
  • Corbus Pharmaceuticals Holdings, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $6,288,000, a 2.3% increase year-over-year.
  • Corbus Pharmaceuticals Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $6,288,000, a 2.3% increase from 2024.
  • Corbus Pharmaceuticals Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $6,145,000, a 77% increase from 2023.
  • Corbus Pharmaceuticals Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3,470,000, a 39% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Corbus Pharmaceuticals Holdings, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $6,288,000 $1,429,000 -$3,424,775 -71% 01 Oct 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 $9,712,775 $1,582,000 +$1,579,757 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $8,133,018 $1,563,000 +$275,000 +21% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $7,858,018 $1,714,000 +$1,713,018 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $6,145,000 $4,853,775 +$4,054,154 +507% 01 Oct 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 $2,090,846 $2,243* -$818,757 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $2,909,603 $1,288,000 +$465,000 +57% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025 2025 Q2
Q1 2024 $2,444,603 $982* -$1,025,397 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 $3,470,000 $799,621 -$469,655 -37% 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 $3,939,655 $821,000 -$524,526 -39% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $4,464,181 $823,000 -$690,089 -46% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $5,154,270 $1,026,379 -$565,367 -36% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $5,719,637 $1,269,276 -$524,176 -29% 01 Oct 2022 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 $6,243,813 $1,345,526 -$1,253,721 -48% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 $7,497,534 $1,513,089 -$994,183 -40% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $8,491,717 $1,591,746 -$988,656 -38% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $9,480,373 $1,793,452 -$548,002 -23% 01 Oct 2021 31 Dec 2021 10-K 07 Mar 2023 2022 FY
Q3 2021 $10,028,375 $2,599,247 -$1,031,749 -28% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $11,060,124 $2,507,272 -$840,988 -25% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $11,901,112 $2,580,402 -$557,117 -18% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $12,458,229 $2,341,454 01 Oct 2020 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q3 2020 $3,630,996 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $3,348,260 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $3,137,519 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q1 2017 $171,000 01 Jan 2017 31 Mar 2017 10-K 12 Mar 2019 2018 FY

Corbus Pharmaceuticals Holdings, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $6,288,000 +$143,000 +2.3% 01 Jan 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
2024 $6,145,000 +$2,675,000 +77% 01 Jan 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
2023 $3,470,000 -$2,249,637 -39% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
2022 $5,719,637 -$3,760,736 -40% 01 Jan 2022 31 Dec 2022 10-K 12 Mar 2024 2023 FY
2021 $9,480,373 -$2,977,856 -24% 01 Jan 2021 31 Dec 2021 10-K 07 Mar 2023 2022 FY
2020 $12,458,229 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2022 2021 FY
2016 $222,000 01 Jan 2016 31 Dec 2016 10-K 12 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.